project id: TCGA-COAD; case submitter id: TCGA-AD-6895; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 84; days to birth: -30879; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1927; age at diagnosis: 30879; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 763.0; icd 10 code: C18.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: Not Reported; tissue or organ of origin: Cecum; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 26.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.3; longest dimension: 0.3; oct embedded: No; shortest dimension: 0.1; portion submitter id: TCGA-AD-6895-01A-11; percent lymphocyte infiltration: 5.0; percent necrosis: 2.0; percent normal cells: 0.0; percent stromal cells: 13.0; percent tumor cells: 85.0; percent tumor nuclei: 80.0;